Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAmneal Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Amneal Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 17, 2026BUCHI J KEVINDirector20,445Class A Common Stock$347.8KGift given
Sep 11, 2026BUCHI J KEVINDirector20,445Class A Common Stock$347.8KOption exercise
Sep 1, 2026BOYER ANDREW SExecutive Vice President80,000Class A Common Stock$1.4MGift given
Aug 21, 2026BOYER ANDREW SExecutive Vice President152,426Class A Common Stock$2.7MGift given
Aug 13, 2026Kiely JohnDirector10,000Class A Common Stock$181.4KGift given
Aug 13, 2026Kiely JohnDirector50,000Class A Common Stock$907KSell
Aug 12, 2026Daly Jason B.EVP, Chief Legal Officer210,000Class A Common Stock$3.8MSell
Aug 12, 2026Shah NikitaExecutive Vice President146,403Class A Common Stock$2.7MSell
Aug 11, 2026BUCHI J KEVINDirector168,573Class A Common Stock$3.1MExercise / conversion
Aug 11, 2026Daly Jason B.EVP, Chief Legal Officer6,613Class A Common Stock$120KSell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
$19.50Close · Sep 22, 2026